Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viral Kinetics of Pegasys vs PEG-Intron in Chronic Hepatitis C
NCT00087607Phase 4Completed
- Sponsor
- Roche
- Start
- Jan 2004
- Primary completion
- Mar 2006
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of peginterferon alfa-2a in hepatitis C (HCV) (2 arms), sponsored by Roche. Primary endpoint: Change From Baseline in Viral Load (log10 Reduction) at Week 12. Started Jan 2004; status: completed.
02
Drugs
peginterferon alfa-2a
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00087607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087607.